Assessment of some circulating long non-coding RNAs in lymphomatic Egyptian patients / Aya Mohamed Mahmoud Hamouda Elabd ; Supervised Sherine Maher Rizk , Mahmoud Ahmed Senousy , Raafat Ragaie Abdelmalek
Material type: TextLanguage: English Publication details: Cairo : Aya Mohamed Mahmoud Hamouda Elabd , 2021Description: 102 P. : charts , facsimiles ; 25cmOther title:- تقييم بعض الأحماض النووية الريبوزية الطويلة غير المشفرة فى دم المرضى المصريين المصابين بسرطان الخلايا الليمفاوية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.01.M.Sc.2021.Ay.A (Browse shelf(Opens below)) | Not for loan | 01010110084742000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.01.M.Sc.2021.Ay.A (Browse shelf(Opens below)) | 84742.CD | Not for loan | 01020110084742000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Biochemistry
The reliable identification of diffuse large B-cell lymphoma (DLBCL)-specific targets owns huge implications for its diagnosis and treatment. Long non-coding RNAs (lncRNAs) are implicated in DLBCL pathogenesis; however, circulating DLBCL-related lncRNAs are barely investigated. The present study investigated plasma lncRNAs; HOX transcript antisense intergenic RNA (HOTAIR), Long intergenic RNA (Linc-p21), Growth arrest-specific 5 (GAS5) and X- inactive-specific transcript (XIST) as biomarkers for DLBCL diagnosis and responsiveness to Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy. Eighty-four DLBCL patients and thirty-three healthy controls were included. Only plasma HOTAIR, XIST and GAS5 were differentially expressed in DLBCL patients compared to controls. Pretreatment plasma HOTAIR was higher, whereas GAS5 was lower in non-responders than responders to R-CHOP. Plasma GAS5 was demonstrated superior diagnostic accuracy (AUC=0.97) whereas a panel of HOTAIR+GAS5 were superiorly discriminated responders from non-responders by receiver operating characteristics (ROC) analysis. In multivariate analysis, HOTAIR was an independent predictor of non-response. Among patients, plasma HOTAIR, Linc-p21 and XIST were correlated. Plasma GAS5 was negatively correlated with international prognostic index (IPI), whereas HOTAIR was positively correlated with performance status, denoting their prognostic potential
Issued also as CD
There are no comments on this title.